Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT01038856
Status:
TERMINATED
Last Update Posted:
2020-08-24
First Post:
2009-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
Sponsor:
University of Oklahoma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-22
First Submit QC Date:
None
Study First Post Date:
2009-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-28
Results First Submit QC Date:
None
Results First Post Date:
2018-02-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-07
Last Update Post Date:
2020-08-24
Last Update Post Date Type:
ACTUAL